RSV-attributable outcome/100,000 (range) | |||
---|---|---|---|
Age | Low Risk Population* | High Risk Population* | |
GP episodes | 18-49 | 595 (377–771) | 1344 (924–1598) |
50-64 | 1067 (721–1295) | 2221 (1581–2561) | |
65-74 | 1239 (884–1432) | 2508 (1764–2905) | |
75+ | 1466 (1070–1732) | 2860 (1948–3441) | |
Hospitalisations | 18-49 | 3 (2–5) | 10 (8–13) |
50-64 | 9 (6–10) | 102 (72–117) | |
65-74 | 20 (14–23) | 180 (127–208) | |
75+ | 116 (91–148) | 338 (250–405) | |
Deaths | 18-49 | 0 (0–0) | 4 (3–5) |
50-64 | 2 (1–2) | 22 (15–27) | |
65-74 | 9 (7–11) | 58 (40–69) | |
75+ | 133 (86–189) | 176 (134–233) |